Trials / Recruiting
RecruitingNCT06885931
Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
Exploratory Safety and Feasibility Study of Personalized Adaptive Pudendal Neuromodulation for Mixed Urinary Incontinence and Extended Indications Using an Implanted (Picostim IITM) System
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Amber Therapeutics Ltd · Industry
- Sex
- Female
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Exploratory safety and feasibility study of personalized adaptive pudendal neuromodulation for mixed urinary incontinence and extended indications using an implanted (Picostim™ II) system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pudendal neuromodulation | In this feasibility study, all subjects will receive the Amber UI system. |
Timeline
- Start date
- 2025-06-24
- Primary completion
- 2027-02-01
- Completion
- 2029-08-01
- First posted
- 2025-03-20
- Last updated
- 2026-03-19
Locations
5 sites across 3 countries: Belgium, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT06885931. Inclusion in this directory is not an endorsement.